Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
125.88
+1.32 (1.06%)
Jun 3, 2025, 1:12 PM - Market open

Neurocrine Biosciences Stock Forecast

Stock Price Forecast

According to 20 professional analysts, the 12-month price target for Neurocrine Biosciences stock ranges from a low of $115 to a high of $219. The average analyst price target of $163.2 forecasts a 29.65% increase in the stock price over the next year.

Price Target: $163.20 (+29.65%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $115 $163.2 $160 $219
Change -8.64% +29.65% +27.11% +73.98%

Analyst Ratings

The average analyst rating for Neurocrine Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 566777
Buy 111111111111
Hold 544222
Sell 000000
Strong Sell 000000
Total 212121202020

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Reiterates
$145
Buy Reiterates $145 +15.19% Jun 2, 2025
Piper Sandler
Piper Sandler
Buy
Reiterates
$160$154
Buy Reiterates $160$154 +22.34% May 6, 2025
RBC Capital
RBC Capital
Buy
Maintains
$137$145
Buy Maintains $137$145 +15.19% May 6, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$155$165
Strong Buy Maintains $155$165 +31.08% May 6, 2025
BMO Capital
BMO Capital
Hold
Maintains
$96$115
Hold Maintains $96$115 -8.64% May 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.73B
from 2.36B
Increased by 15.99%
Revenue Next Year
3.14B
from 2.73B
Increased by 14.93%
EPS This Year
4.01
from 3.29
Increased by 21.88%
EPS Next Year
6.42
from 4.01
Increased by 60.13%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.05B1.13B1.49B1.89B2.36B2.73B3.14B3.53B
Revenue Growth
32.71%8.38%31.34%26.76%24.81%15.99%14.93%12.26%
EPS
4.160.921.562.473.294.016.428.46
EPS Growth
966.67%-77.89%69.57%58.33%33.20%21.88%60.13%31.70%
Forward PE
-----31.3919.6014.89
No. Analysts
-----272620
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 2.9B 3.4B 4.0B
Avg 2.7B 3.1B 3.5B
Low 2.5B 2.8B 3.0B

Revenue Growth

Revenue Growth 20252026202720282029
High
22.0%
25.0%
26.5%
Avg
16.0%
14.9%
12.3%
Low
8.2%
1.0%
-3.2%

EPS Forecast

EPS 20252026202720282029
High 4.92 9.80 12.01
Avg 4.01 6.42 8.46
Low 2.88 4.03 3.53

EPS Growth

EPS Growth 20252026202720282029
High
49.7%
144.3%
87.1%
Avg
21.9%
60.1%
31.7%
Low
-12.4%
0.4%
-45.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.